This current issues session will feature competing arguments for either obesity or glucose control as the primary target of treatment in type 2 diabetes, as well as a question and discussion period at the end. The session will begin at 1:45 p.m. CT on Saturday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.